Detalhe da pesquisa
1.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Lancet
; 403(10442): 2416-2425, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38763153
2.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Lancet
; 403(10442): 2405-2415, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38763154
3.
Safety and effectiveness of the radium-223-taxane treatment sequence in patients with metastatic castration-resistant prostate cancer in a global observational study (REASSURE).
Cancer
; 130(11): 1930-1939, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340349
4.
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.
Lancet
; 396(10260): 1413-1421, 2020 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33002429
5.
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Lancet Oncol
; 17(8): 1047-1060, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27339115
6.
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Lancet Oncol
; 16(16): 1605-16, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26522334
7.
Intermittent androgen suppression for rising PSA level after radiotherapy.
N Engl J Med
; 367(10): 895-903, 2012 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22931259
8.
Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial.
Lancet Oncol
; 15(12): 1397-406, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25439694
9.
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.
Lancet Oncol
; 15(7): 738-46, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24836273
10.
Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UK.
BJU Int
; 113(5): 748-53, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24053230
11.
SABRE 1 (Surgery Against Brachytherapy - a Randomised Evaluation): feasibility randomised controlled trial (RCT) of brachytherapy vs radical prostatectomy in low-intermediate risk clinically localised prostate cancer.
BJU Int
; 112(3): 330-7, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23826842
12.
Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-RT Trial.
Int J Radiat Oncol Biol Phys
; 117(3): 624-629, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37150260
13.
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST).
J Clin Oncol
; 40(22): 2468-2478, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35298280
14.
Early prostate cancer--which treatment do men prefer and why?
BJU Int
; 107(11): 1762-8, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21083643
15.
Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016).
Eur Urol Oncol
; 4(6): 980-992, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34489210
16.
Tracer kinetic analysis of dynamic contrast-enhanced MRI and CT bladder cancer data: A preliminary comparison to assess the magnitude of water exchange effects.
Magn Reson Med
; 64(2): 595-603, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20665802
17.
Ten-Year Outcomes of Moderately Hypofractionated Salvage Postprostatectomy Radiation Therapy and External Validation of a Contemporary Multivariable Nomogram for Biochemical Failure.
Int J Radiat Oncol Biol Phys
; 107(2): 288-296, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31987961
18.
Palliative Radiation Therapy in Bladder Cancer-Importance of Patient Selection: A Retrospective Multicenter Study.
Int J Radiat Oncol Biol Phys
; 105(2): 389-393, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31283979
19.
Late tissue effects following radiotherapy and neoadjuvant hormone therapy of the prostate measured with quantitative magnetic resonance imaging.
Radiother Oncol
; 88(1): 127-34, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18342969
20.
Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer.
Radiother Oncol
; 88(1): 102-7, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18453022